AprilBio Co Ltd (397030)

Currency in KRW
47,650.00
-600.00(-1.24%)
Delayed Data·
397030 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
45,050.0049,400.00
52 wk Range
11,980.0060,000.00
Key Statistics
Bid/Ask
47,550.00 / 47,650.00
Prev. Close
48,250
Open
49,200
Day's Range
45,050-49,400
52 wk Range
11,980-60,000
Volume
266.72K
Average Volume (3m)
1.09M
1-Year Change
204.2784%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
397030 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
50,000.00
Upside
+4.93%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

AprilBio Company Profile

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

Compare 397030 to Peers and Sector

Metrics to compare
397030
Peers
Sector
Relationship
P/E Ratio
−1,275.9x−11.9x−0.6x
PEG Ratio
11.48−0.300.00
Price/Book
12.4x3.5x2.6x
Price / LTM Sales
124.8x19.8x3.4x
Upside (Analyst Target)
3.6%0.0%42.5%
Fair Value Upside
Unlock9.7%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 50,000.00
(+4.93% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-219.00 / 14.00
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

68,700.00
437730
-3.78%
107,000
058610
-3.43%
78,800.00
347850
-1.62%
77,600.00
468530
+2.24%
15,930
085660
-2.39%

FAQ

What Is the AprilBio (397030) Share Price Today?

The live AprilBio share price today is 47,650.00

What Stock Exchange Does AprilBio (397030) Trade On?

AprilBio is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for AprilBio?

The stock symbol (also called a 'ticker') for AprilBio is "397030."

What Is the Current AprilBio Market Cap?

As of today, AprilBio market capitalisation is 1.12T.

What Is AprilBio's (397030) Earnings Per Share (TTM)?

The AprilBio EPS is currently -39.00 (Trailing Twelve Months).

Is 397030 a Buy or Sell From a Technical Analyst Perspective?

Based on today's AprilBio moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has AprilBio Stock Split?

AprilBio has split 1 times. (See the 397030 stock split history page for full effective split date and price information.)

What is the current trading status of AprilBio (397030)?

As of 22 Jan 2026, AprilBio (397030) is trading at a price of 47,650.00, with a previous close of 48,250.00. The stock has fluctuated within a day range of 45,050.00 to 49,400.00, while its 52-week range spans from 11,980.00 to 60,000.00.

What Is AprilBio (397030) Price Target According to Analysts?

The average 12-month price target for AprilBio is KRW50,000.00, with a high estimate of KRW50000 and a low estimate of KRW50000. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +4.93% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.